Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
908 Devices is a commercial-stage life science technology company that develops and manufactures handheld and desktop mass spectrometry (Mass Spec) devices. The company's proprietary platform miniaturizes high-performance mass spectrometry technology, enabling point-of-need chemical analysis that traditionally required large, benchtop laboratory equipment. Its products, such as the MX908 and Rebel, are utilized across various sectors including life sciences research, bioprocessing, industrial biotechnology, and forensics. By providing rapid, actionable insights at the point of need, 908 Devices aims to enhance operational efficiency and safety for pharmaceutical companies, research institutions, and government agencies globally.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Mass Financial.